Molecular Pathology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ellison, G
Right arrow Articles by Fox, J C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ellison, G
Right arrow Articles by Fox, J C
Molecular Pathology 2002;55:294-299
© 2002 Journal of Clinical Pathology


ORIGINAL ARTICLE

Further evidence to support the melanocytic origin of MDA-MB-435

G Ellison, T Klinowska, R F R Westwood, E Docter, T French and J C Fox

AstraZeneca, Mereside, Alderley Park, Macclesfield SK10 4TG, UK

Correspondence to:
Dr G Ellison, AstraZeneca, 19G22, Mereside, Alderely Park, Macclesfield SK10 4TG, UK;
gillian.ellison{at}astrazeneca.com

Background/Aims: Until recently, the cell line MDA-MB-435 was widely accepted as originating from a breast cancer. However, microarray derived data have suggested that this cell line may in fact originate from an occult melanoma. This study was designed to investigate this hypothesis further.

Methods: Quantitative reverse transcription polymerase chain reaction and immunohistochemistry were used to investigate the tissue of origin of two sublines of MDA-MB-435 (MDA-MB-435 S and MDA-MB-435 HGF). The expression of a panel of genes typical of breast cells or melanocytes was analysed.

Results: The MDA-MD-435 cell lines expressed none of the genes characteristic of breast cancer cells but did express several genes commonly expressed by melanocytes.

Conclusions: These results strongly suggest that MDA-MB-435 is indeed of melanoma origin.


Keywords: MDA-MB-435 cell line; quantitative reverse transcription polymerase chain reaction; melanoma

Abbreviations: ATCC, American Type Culture Collection; DAB, diaminobenzidine; ECACC, European Collection of Cell Cultures; EMA, epithelial membrane antigen; FCS, fetal calf serum; HGF, hepatocyte growth factor; HPRT, hypoxanthine ribosyl transferase; NEAA, non-essential amino acids; RT-PCR, reverse transcription polymerase chain reaction; SCID, severe combined immunodeficient




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Ehrich, J. Turner, P. Gibbs, L. Lipton, M. Giovanneti, C. Cantor, and D. van den Boom
Cytosine methylation profiling of cancer cell lines
PNAS, March 25, 2008; 105(12): 4844 - 4849.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. A. Phadke, K. S. Vaidya, K. T. Nash, D. R. Hurst, and D. R. Welch
BRMS1 Suppresses Breast Cancer Experimental Metastasis to Multiple Organs by Inhibiting Several Steps of the Metastatic Process
Am. J. Pathol., March 1, 2008; 172(3): 809 - 817.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Shen, S. Chu, A. K. Bence, B. Bailey, X. Xue, P. A. Erickson, M. H. Montrose, W. T. Beck, and L. C. Erickson
Quantitation of Doxorubicin Uptake, Efflux, and Modulation of Multidrug Resistance (MDR) in MDR Human Cancer Cells
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 95 - 102.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
W. C. Reinhold, M. A. Reimers, A. K. Maunakea, S. Kim, S. Lababidi, U. Scherf, U. T. Shankavaram, M. S. Ziegler, C. Stewart, H. Kouros-Mehr, et al.
Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells
Mol. Cancer Ther., February 1, 2007; 6(2): 391 - 403.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
P L Jeffery, R E Murray, A H Yeh, J F McNamara, R P Duncan, G D Francis, A C Herington, and L K Chopin
Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines
Endocr. Relat. Cancer, December 1, 2005; 12(4): 839 - 850.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
M. G. Hollingshead, J. P. Carter, K. Dougherty, and C. A. Bonomi
The Hollow Fiber Assay in Cancer Efficacy Testing in the Developmental Therapeutics Program at the National Cancer Institute
Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 351 - 354.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Sandberg and I. Ernberg
Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI)
PNAS, February 8, 2005; 102(6): 2052 - 2057.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Moroni, V. Soldatenkov, L. Zhang, Y. Zhang, G. Stoica, E. Gehan, B. Rashidi, B. Singh, M. Ozdemirli, and S. C. Mueller
Progressive Loss of Syk and Abnormal Proliferation in Breast Cancer Cells
Cancer Res., October 15, 2004; 64(20): 7346 - 7354.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. C. Alley, M. G. Hollingshead, C. M. Pacula-Cox, W. R. Waud, J. A. Hartley, P. W. Howard, S. J. Gregson, D. E. Thurston, and E. A. Sausville
SJG-136 (NSC 694501), A Novel Rationally Designed DNA Minor Groove Interstrand Cross-Linking Agent with Potent and Broad Spectrum Antitumor Activity: Part 2: Efficacy Evaluations
Cancer Res., September 15, 2004; 64(18): 6700 - 6706.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. E. Duncan, A. El-Sohemy, and M. C. Archer
Mevalonate Promotes the Growth of Tumors Derived from Human Cancer Cells in Vivo and Stimulates Proliferation in Vitro with Enhanced Cyclin-dependent Kinase-2 Activity
J. Biol. Chem., August 6, 2004; 279(32): 33079 - 33084.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Liang, T. Wu, H. Lou, X. Yu, R. S. Taichman, S. K. Lau, S. Nie, J. Umbreit, and H. Shim
Inhibition of Breast Cancer Metastasis by Selective Synthetic Polypeptide against CXCR4
Cancer Res., June 15, 2004; 64(12): 4302 - 4308.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Sellappan, R. Grijalva, X. Zhou, W. Yang, M. B. Eli, G. B. Mills, and D. Yu
Lineage Infidelity of MDA-MB-435 Cells: Expression of Melanocyte Proteins in a Breast Cancer Cell Line
Cancer Res., May 15, 2004; 64(10): 3479 - 3485.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Sachdev, J. S. Hartell, A. V. Lee, X. Zhang, and D. Yee
A Dominant Negative Type I Insulin-like Growth Factor Receptor Inhibits Metastasis of Human Cancer Cells
J. Biol. Chem., February 6, 2004; 279(6): 5017 - 5024.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
Y. Huang, J. C. Keen, E. Hager, R. Smith, A. Hacker, B. Frydman, A. L. Valasinas, V. K. Reddy, L. J. Marton, R. A. Casero Jr., et al.
Regulation of Polyamine Analogue Cytotoxicity by c-Jun in Human MDA-MB-435 Cancer Cells
Mol. Cancer Res., February 1, 2004; 2(2): 81 - 88.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Kremer, L. Quintanilla-Martinez, M. Fuchs, A. Gamboa-Dominguez, S. Haye, H. Kalthoff, E. Rosivatz, C. Hermannstadter, R. Busch, H. Hofler, et al.
Influence of tumor-associated E-cadherin mutations on tumorigenicity and metastasis
Carcinogenesis, December 1, 2003; 24(12): 1879 - 1886.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Huang, E. R. Hager, D. L. Phillips, V. R. Dunn, A. Hacker, B. Frydman, J. A. Kink, A. L. Valasinas, V. K. Reddy, L. J. Marton, et al.
A Novel Polyamine Analog Inhibits Growth and Induces Apoptosis in Human Breast Cancer Cells
Clin. Cancer Res., July 1, 2003; 9(7): 2769 - 2777.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Molecular Pathology Journal of Clinical Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.